How to Use drugmaker in a Sentence

drugmaker

noun

• The product’s list price was $2,100 per dose, the drugmaker said then.
  — Alexander Ruoff, Fortune, 31 Aug. 2022
• The increase was mainly driven by sales of the over-the-counter version, the drugmaker said.
  — Sara G. Miller, NBC News, 11 Mar. 2024
• The drugmaker was aiming to match the rate of Aubagio, an oral drug for the disease owned by Sanofi.
  — David Sachs, WSJ, 6 Dec. 2023
• The pill in the new study — made by the Spanish drugmaker Ferrer — was approved for use in Europe in 2014.
  — Erika Edwards, NBC News, 26 Aug. 2022
• The drugmaker is looking for new products to make up for the huge gap left by the fading pandemic.
  — Madison Muller, Fortune, 1 Dec. 2023
• The specialized tool will help researchers track the virus’ spread and keep tabs on its evolution, the drugmaker said.
  — Robert Hart, Forbes, 26 Jan. 2023
• The drugmaker charges your health plan its normal portion of the drug cost, but the patient doesn't pay their normal copay share.
  — Katie Wedell, USA TODAY, 1 Nov. 2022
• The drugmaker also raised its full-year 2023 sales forecast.
  — WSJ, 1 Aug. 2023
• Hundreds of billions dollars have been spent by drugmakers around the world to try and treat Alzheimer’s, but there’s currently no cure for the disease.
  — Time, 4 July 2023
• Part of this is due to side effects—mostly muscle aches—that were not made clear by drugmakers when statins were first approved.
  — Kaitlin Sullivan, Health, 14 Dec. 2023
• The vaccine brought in $36.78 billion in revenue last year for Pfizer and was the drugmaker’s top-selling product.
  — Tom Murphy, Anchorage Daily News, 21 Oct. 2022
• The vaccine brought in $36.78 billion in revenue last year for Pfizer and was the drugmaker's top-selling product.
  — Tom Murphy, USA TODAY, 22 Oct. 2022
• This is a standard price-setting method among drugmakers.
  — Michael Hiltzik, Los Angeles Times, 24 Mar. 2023
• The drugmaker hasn’t responded to a CNN request for comment.
  — Laura He, CNN, 6 June 2023
• Lilly’s stock-market value has risen to about $670 billion, the largest of any drugmaker tracked by S&P Global.
  — Daniel Gilbert, Washington Post, 8 Feb. 2024
• This study, funded by drugmakers, is the result of that requirement.
  — Karen Weintraub, USA TODAY, 16 June 2023
• If the plan is enacted, drugmakers are almost certain to challenge it in court.
  — Amanda Seitz, Fortune Well, 7 Dec. 2023
• One of the other two treatments as a pill, which drugmakers see as the next frontier for that treatment category.
  — Paula Doenecke, Fortune Europe, 4 Dec. 2023
• Gupta said the Biden administration is asking the drugmakers to keep the price of the antidote low.
  — Nadia Kounang, CNN, 29 Mar. 2023
• Bagley told me by email that even if that’s a genuine flaw, the remedy is either to let the drugmakers withdraw right away or give them a bit more time to keep charging full price.
  — Michael Hiltzik, Los Angeles Times, 15 June 2023
• But Medicare this year set strict limitations on the drug's use, and its drugmaker has since cut the medication's cost in half.
  — CBS News, 28 Sep. 2022
• The drugmaker has now announced deals valued at a total of nearly $19 billion, counting debt, since late last year.
  — Tom Murphy and Michelle Chapman, Chicago Tribune, 8 Aug. 2022
• The Swiss drugmaker will pay 68 euros, or around $73, per share, nearly twice Morphosys’s average trading price over the last month.
  — Jason Mast, STAT, 5 Feb. 2024
• The drugmaker’s outlook for $22 billion in sales this year from its antiviral Covid-19 treatment, known as Paxlovid, is unchanged from the summer.
  — Charley Grant, WSJ, 1 Nov. 2022
• The drugmaker has also stopped retailers and food suppliers in their tracks.
  — Byryan Hogg, Fortune Europe, 31 Jan. 2024
• Pfizer will pay $229 a share in cash for Seagen, according a statement Monday, about a third more than the drugmaker’s closing share price Friday.
  — Naomi Kresge, Chicago Tribune, 13 Mar. 2023
• The drugmaker found that 2.3% of study subjects who were randomly assigned to take Paxlovid suffered a relapse — but so did 1.7% of subjects who took a placebo.
  — Karen Kaplan, Los Angeles Times, 15 Nov. 2022
• Shares of the Danish drugmaker have soared 40% so far this year, boosted by an explosion in demand for its weight-loss drugs Wegovy and Ozempic.
  — Hanna Ziady, CNN, 5 Sep. 2023
• The treatment has evolved from drugs that had been injected daily to once a week, and drugmakers are developing a pill version.
  — Daniel Gilbert, Anchorage Daily News, 12 June 2023
• The pause on the lower court ruling came after an appeal from the Biden administration and drugmakers.
  — Kirsty Hatcher, Peoplemag, 20 Apr. 2023

Last Updated: 7 May 2024